-- 
Almirall Signs Accord With Nycomed to Sell Ebastina in China

-- B y   C h a r l e s   P e n t y
-- 
2011-09-29T15:35:20Z

-- http://www.bloomberg.com/news/2011-09-29/almirall-signs-accord-with-nycomed-to-sell-ebastina-in-china.html
Almirall SA (ALM)  signed an accord with
Nycomed to sell its antihistamine treatment ebastina in  China 
and  Southeast Asia , the company said in a filing. Nycomed will
have exclusive rights to sell Almirallâ€™s drug under the Kestine
brand in those markets, the company said.  To contact the editor responsible for this story:
Charles Penty at 
 cpenty@bloomberg.net  